Orland Park Integrated Health,ltd. - Medicare in Orland Park, IL

Orland Park Integrated Health,ltd. is a medicare enrolled "Physical Medicine & Rehabilitation" provider in Orland Park, Illinois. Their current practice location is 9441 W 144th Pl Ste 200, Orland Park, Illinois. You can reach out to their office (for appointments etc.) via phone at (708) 403-2727.

Orland Park Integrated Health,ltd. is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Orland Park Integrated Health,ltd. is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1144766882.

Contact Information

Orland Park Integrated Health,ltd.
9441 W 144th Pl Ste 200,
Orland Park, IL 60462-2543
(708) 403-2727
(708) 403-2770



Healthcare Provider's Profile

Full NameOrland Park Integrated Health,ltd.
TypeFacility
SpecialityPhysical Medicine & Rehabilitation
Location9441 W 144th Pl Ste 200, Orland Park, Illinois
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1144766882
  • Provider Enumeration Date: 01/18/2017
  • Last Update Date: 01/18/2017
  Medicare PECOS Information:
  • PECOS PAC ID: 7315222437
  • Enrollment ID: O20170331001409

Medical Identifiers

Medical identifiers for Orland Park Integrated Health,ltd. such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1144766882NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
111N00000XChiropractor (* (Not Available))Secondary
111NR0400XChiropractor - Rehabilitation (* (Not Available))Secondary
207RE0101XInternal Medicine - Endocrinology, Diabetes & Metabolism (* (Not Available))Secondary
207RS0010XInternal Medicine - Sports Medicine (* (Not Available))Secondary
207XX0005XOrthopaedic Surgery - Sports Medicine (* (Not Available))Secondary
208100000XPhysical Medicine & Rehabilitation (* (Not Available))Primary
225100000XPhysical Therapist (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Orland Park Integrated Health,ltd. acts as a billing entity for following providers:
Provider NameRobert T Wright
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1245239474
PECOS PAC ID: 1153226394
Enrollment ID: I20031202000149

News Archive

COPAN awarded Japanese patent for invention of flocked swabs

COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).

Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has received a milestone payment from its partner Roche related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate.

Longer looks: A surgeon examines his professional development

I've been a surgeon for eight years. For the past couple of them, my performance in the operating room has reached a plateau. I'd like to think it's a good thing-;I've arrived at my professional peak. But mainly it seems as if I've just stopped getting better. During the first two or three years in practice, your skills seem to improve almost daily. It's not about hand-eye coördination-;you have that down halfway through your residency.

Study reveals new way to target HER2-negative metastatic breast cancer

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Stroke incidence and treatment: Racial and geographic disparities

Blacks are more likely to have an undiagnosed key risk factor for stroke and are more likely to have a stroke than whites, according to two studies presented at the American Stroke Association's International Stroke Conference 2010.

Read more Medical News

› Verified 9 days ago

Provider NameRushia Butler
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1376582072
PECOS PAC ID: 6608779038
Enrollment ID: I20040131000255

News Archive

COPAN awarded Japanese patent for invention of flocked swabs

COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).

Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has received a milestone payment from its partner Roche related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate.

Longer looks: A surgeon examines his professional development

I've been a surgeon for eight years. For the past couple of them, my performance in the operating room has reached a plateau. I'd like to think it's a good thing-;I've arrived at my professional peak. But mainly it seems as if I've just stopped getting better. During the first two or three years in practice, your skills seem to improve almost daily. It's not about hand-eye coördination-;you have that down halfway through your residency.

Study reveals new way to target HER2-negative metastatic breast cancer

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Stroke incidence and treatment: Racial and geographic disparities

Blacks are more likely to have an undiagnosed key risk factor for stroke and are more likely to have a stroke than whites, according to two studies presented at the American Stroke Association's International Stroke Conference 2010.

Read more Medical News

› Verified 9 days ago

Provider NameKrishna D Parameswar
Provider TypePractitioner - Physical Medicine And Rehabilitation
Provider IdentifiersNPI Number: 1780620690
PECOS PAC ID: 2769414101
Enrollment ID: I20050907000060

News Archive

COPAN awarded Japanese patent for invention of flocked swabs

COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).

Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has received a milestone payment from its partner Roche related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate.

Longer looks: A surgeon examines his professional development

I've been a surgeon for eight years. For the past couple of them, my performance in the operating room has reached a plateau. I'd like to think it's a good thing-;I've arrived at my professional peak. But mainly it seems as if I've just stopped getting better. During the first two or three years in practice, your skills seem to improve almost daily. It's not about hand-eye coördination-;you have that down halfway through your residency.

Study reveals new way to target HER2-negative metastatic breast cancer

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Stroke incidence and treatment: Racial and geographic disparities

Blacks are more likely to have an undiagnosed key risk factor for stroke and are more likely to have a stroke than whites, according to two studies presented at the American Stroke Association's International Stroke Conference 2010.

Read more Medical News

› Verified 9 days ago

Provider NameEric A Miller
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1689694333
PECOS PAC ID: 3870509995
Enrollment ID: I20060228000033

News Archive

COPAN awarded Japanese patent for invention of flocked swabs

COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).

Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has received a milestone payment from its partner Roche related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate.

Longer looks: A surgeon examines his professional development

I've been a surgeon for eight years. For the past couple of them, my performance in the operating room has reached a plateau. I'd like to think it's a good thing-;I've arrived at my professional peak. But mainly it seems as if I've just stopped getting better. During the first two or three years in practice, your skills seem to improve almost daily. It's not about hand-eye coördination-;you have that down halfway through your residency.

Study reveals new way to target HER2-negative metastatic breast cancer

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Stroke incidence and treatment: Racial and geographic disparities

Blacks are more likely to have an undiagnosed key risk factor for stroke and are more likely to have a stroke than whites, according to two studies presented at the American Stroke Association's International Stroke Conference 2010.

Read more Medical News

› Verified 9 days ago

Provider NameRonald Lester Berger
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1902040595
PECOS PAC ID: 3274685185
Enrollment ID: I20090903000590

News Archive

COPAN awarded Japanese patent for invention of flocked swabs

COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).

Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has received a milestone payment from its partner Roche related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate.

Longer looks: A surgeon examines his professional development

I've been a surgeon for eight years. For the past couple of them, my performance in the operating room has reached a plateau. I'd like to think it's a good thing-;I've arrived at my professional peak. But mainly it seems as if I've just stopped getting better. During the first two or three years in practice, your skills seem to improve almost daily. It's not about hand-eye coördination-;you have that down halfway through your residency.

Study reveals new way to target HER2-negative metastatic breast cancer

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Stroke incidence and treatment: Racial and geographic disparities

Blacks are more likely to have an undiagnosed key risk factor for stroke and are more likely to have a stroke than whites, according to two studies presented at the American Stroke Association's International Stroke Conference 2010.

Read more Medical News

› Verified 9 days ago

Provider NameHester J Hursh
Provider TypePractitioner - Orthopedic Surgery
Provider IdentifiersNPI Number: 1982701694
PECOS PAC ID: 7214112168
Enrollment ID: I20131211000153

News Archive

COPAN awarded Japanese patent for invention of flocked swabs

COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).

Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has received a milestone payment from its partner Roche related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate.

Longer looks: A surgeon examines his professional development

I've been a surgeon for eight years. For the past couple of them, my performance in the operating room has reached a plateau. I'd like to think it's a good thing-;I've arrived at my professional peak. But mainly it seems as if I've just stopped getting better. During the first two or three years in practice, your skills seem to improve almost daily. It's not about hand-eye coördination-;you have that down halfway through your residency.

Study reveals new way to target HER2-negative metastatic breast cancer

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Stroke incidence and treatment: Racial and geographic disparities

Blacks are more likely to have an undiagnosed key risk factor for stroke and are more likely to have a stroke than whites, according to two studies presented at the American Stroke Association's International Stroke Conference 2010.

Read more Medical News

› Verified 9 days ago

Provider NameJenna Chavka
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1053711283
PECOS PAC ID: 5597080523
Enrollment ID: I20150213000653

News Archive

COPAN awarded Japanese patent for invention of flocked swabs

COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).

Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has received a milestone payment from its partner Roche related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate.

Longer looks: A surgeon examines his professional development

I've been a surgeon for eight years. For the past couple of them, my performance in the operating room has reached a plateau. I'd like to think it's a good thing-;I've arrived at my professional peak. But mainly it seems as if I've just stopped getting better. During the first two or three years in practice, your skills seem to improve almost daily. It's not about hand-eye coördination-;you have that down halfway through your residency.

Study reveals new way to target HER2-negative metastatic breast cancer

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Stroke incidence and treatment: Racial and geographic disparities

Blacks are more likely to have an undiagnosed key risk factor for stroke and are more likely to have a stroke than whites, according to two studies presented at the American Stroke Association's International Stroke Conference 2010.

Read more Medical News

› Verified 9 days ago

Provider NameRita Dianati
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1902938673
PECOS PAC ID: 9133405392
Enrollment ID: I20170424002423

News Archive

COPAN awarded Japanese patent for invention of flocked swabs

COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).

Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has received a milestone payment from its partner Roche related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate.

Longer looks: A surgeon examines his professional development

I've been a surgeon for eight years. For the past couple of them, my performance in the operating room has reached a plateau. I'd like to think it's a good thing-;I've arrived at my professional peak. But mainly it seems as if I've just stopped getting better. During the first two or three years in practice, your skills seem to improve almost daily. It's not about hand-eye coördination-;you have that down halfway through your residency.

Study reveals new way to target HER2-negative metastatic breast cancer

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Stroke incidence and treatment: Racial and geographic disparities

Blacks are more likely to have an undiagnosed key risk factor for stroke and are more likely to have a stroke than whites, according to two studies presented at the American Stroke Association's International Stroke Conference 2010.

Read more Medical News

› Verified 9 days ago

Provider NameVincent Tupper
Provider TypePractitioner - Interventional Pain Management
Provider IdentifiersNPI Number: 1609139583
PECOS PAC ID: 1557643368
Enrollment ID: I20170509000221

News Archive

COPAN awarded Japanese patent for invention of flocked swabs

COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).

Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has received a milestone payment from its partner Roche related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate.

Longer looks: A surgeon examines his professional development

I've been a surgeon for eight years. For the past couple of them, my performance in the operating room has reached a plateau. I'd like to think it's a good thing-;I've arrived at my professional peak. But mainly it seems as if I've just stopped getting better. During the first two or three years in practice, your skills seem to improve almost daily. It's not about hand-eye coördination-;you have that down halfway through your residency.

Study reveals new way to target HER2-negative metastatic breast cancer

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Stroke incidence and treatment: Racial and geographic disparities

Blacks are more likely to have an undiagnosed key risk factor for stroke and are more likely to have a stroke than whites, according to two studies presented at the American Stroke Association's International Stroke Conference 2010.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Orland Park Integrated Health,ltd. is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Orland Park Integrated Health,ltd.
9441 W 144th Pl Ste 200,
Orland Park, IL 60462-2543

Ph: (708) 403-2727
Orland Park Integrated Health,ltd.
9441 W 144th Pl Ste 200,
Orland Park, IL 60462-2543

Ph: (708) 403-2727

News Archive

COPAN awarded Japanese patent for invention of flocked swabs

COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of patents held by COPAN across the world for the use of flocked swabs for collection and transfer of biological samples, including the Australian patent (2004226798) granted earlier this year, a European patent that covers several countries (1608268), a Canadian patent (2515205), and New Zealand patent (541560).

Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has received a milestone payment from its partner Roche related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate.

Longer looks: A surgeon examines his professional development

I've been a surgeon for eight years. For the past couple of them, my performance in the operating room has reached a plateau. I'd like to think it's a good thing-;I've arrived at my professional peak. But mainly it seems as if I've just stopped getting better. During the first two or three years in practice, your skills seem to improve almost daily. It's not about hand-eye coördination-;you have that down halfway through your residency.

Study reveals new way to target HER2-negative metastatic breast cancer

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Stroke incidence and treatment: Racial and geographic disparities

Blacks are more likely to have an undiagnosed key risk factor for stroke and are more likely to have a stroke than whites, according to two studies presented at the American Stroke Association's International Stroke Conference 2010.

Read more News

› Verified 9 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.